Mushrooms Inc. Discusses Utility Patent Filing For MYCO Thread Applications on The Stock Day Podcast

ESTERO, FL / ACCESSWIRE / December 8, 2023 / Mushrooms Inc., (OTC PINK:MSRM) The Stock Day Podcast welcomed Mushrooms Inc., a publicly traded company on the OTC Markets with the stock symbol MSRM and is the first industrial mushroom company to be listed on a public exchange.

Stock Day host Matthew Dunehoo began the interview by asking about a recent announcement detailing the Company's full patent filing for its nutrient-delivery textile innovation, MYCO Thread.

"What is it about the nature of the mycelium that allows for the delivery of these compounds in a way that other materials do not?", asked Dunehoo.

Lead Chemist Maqsad Suriev says, "This is sustainable and biodegradable with a vast potential of applications. The bacteria detection alone uses a textile that can aid in controlling and diagnosing bacterial infections," he continued. "This would allow doctors to identify bacteria in real-time. The mycelium is composed of a number of biopolymers, and those biopolymers combined with synthetic enzyme substrates allow the detection of bacteria, as well as nutrient delivery," explained adding that another distinguishing feature of these particular biopolymers include their sustainability and biodegradable properties.

Dunehoo then asked, "What industries do you envision benefitting the most from these technologies?" Senior Lead Scientist, Hyder Khoja says, "This technology has immense potential across many global industries, including both for clothing and healing." The reason this technology is so important is that it is able to detect bacteria immediately and is able to help prevent infection, he continued, adding that the technology could even have applications within the sports and athletic industries with the biopolymers woven into fabric. "There is also efficacy towards the military and aerospace engineering areas, which utilizes protective fabrics and materials," said Khoja. "The mycelium would add another layer of protection."

Dunehoo finished the interview with Kimberly Carlon, the CEO of Mushrooms Inc. by asking, "What are the immediate plans for Mushrooms Inc.?" Kimberly Carlson says, "Funding has been my main focus, and we have identified the bacterial detection bandage as the most valuable Phase 1 launch," she shared. "While we are actively engaging with investors for Phase I and bringing this concept to fruition, simultaneously we are working with leading scientists to develop functional nutraceutical products," said Carlson. "These formulations, once proven in the marketplace, allow us to come out with nutrient delivery, transdermal textiles."

To close the interview, Carlson elaborated on the Company revenue generation plans, as well as the introduction of the marketing strategy for their revolutionary mycelium technologies. Listeners and investors are encouraged to keep up-to-date on the Company's current and upcoming projects as they continue to grow within a number of industries.

To hear Kimberly Carlson's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8413424-mushrooms-inc-discusses-utility-patent-filing-for-myco-thread-applications-on-the-stock-day-podc

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/

About Mushrooms Inc.

Mushrooms Inc. (OTC PINK:MSRM) is a publicly traded company on the OTC Markets with the stock symbol MSRM and is the first industrial mushroom company to be listed on a public exchange. Mushrooms Inc. is a pioneering biotech company, deeply entrenched in the world of mycology. Our primary mission is to harness the transformative potential of Mycelium, especially for groundbreaking applications in the healthcare sector. Our dedicated R&D endeavors are underpinned by advanced technology, ensuring rigorous testing and validation of the manifold health benefits of mushrooms, thereby leading to the formulation of scientifically-backed supplements.

Our recent utility patent underscores our innovation-driven ethos, detailing novel methods for bacterial detection and nutrient delivery using mycelium. This patent stands as a testament to our commitment to intertwining age-old wisdom with contemporary technological advancements, aiming to revolutionize healthcare interventions and amplify overall well-being.

Inspired by the vision and resilience of mycology pioneers, Mushrooms Inc. establishes robust partnerships, resulting in products that champion both human health and environmental sustainability.

Prior Press Releases

1. Mushrooms Inc. (OTC:MSRM) expands on full patent filing for Nutrient-Delivery Textile Innovation, MYCOThread
2. Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
3. Announces Diverse Business Development Team Assembled to Drive Company Growth
4. Poised for Textile Innovation and Global Impact as Full Patent Filing for Mycelium Thread Nears Completion
5. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast
6. Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders
7. Mushrooms, Inc. Announces Name and Ticker Symbol Change on O_T_C_ _M_a_r_k_e_t_s_ _t_o_ _"M_S_R_M_" _

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such

expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

Corporate Contact:

CEO: Kimberly Carlson
Tel: (877) 379-5400
email: info@mushroomsinc.com
www.mushroomsinc.com

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

CONTACT:

Stock Day Media
StockDayMedia.com
(602) 821-1102

SOURCE: Stock Day Media